Treace Medical Concepts
TMCI
132 hedge funds and large institutions have $538M invested in Treace Medical Concepts in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 48 reducing their positions, and 14 closing their positions.
138% more call options, than puts
Call options by funds: $4.22M | Put options by funds: $1.78M
36% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 14
4% more funds holding
Funds holding: 127 → 132 (+5)
2% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 48
4% less capital invested
Capital invested by funds: $563M → $538M (-$24.6M)
4.69% less ownership
Funds ownership: 71.54% → 66.86% (-4.7%)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$18.1M |
| 2 |
PA
Perceptive Advisors
New York
|
+$14.1M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$5.46M |
| 4 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$5.26M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$4.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$39.2M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$21.8M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$7.18M |
| 4 |
AC
Armistice Capital
New York
|
-$6.08M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$4.87M |
TMCI Hedge Fund Activity: Q1 2024 in Review
132 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2024, worth a combined $538M — down 4.4% from $563M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new TMCI positions and 14 closed out — a net gain of 5 holders — while 47 added to existing stakes and 48 trimmed.
The largest buyer was Millennium Management, adding an estimated $18.1M. The largest seller was Morgan Stanley, cutting an estimated $39.2M.
- 132 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2024, up from 127 in Q4 2023.
- Funds reported $538M of Treace Medical Concepts stock for Q1 2024, down 4.4% quarter-over-quarter.
- 19 funds opened new Treace Medical Concepts positions in Q1 2024 and 14 closed out, a net change of +5 holders.
- The largest Treace Medical Concepts buyer in Q1 2024 was Millennium Management, an estimated $18.1M added.
- The largest Treace Medical Concepts seller in Q1 2024 was Morgan Stanley, an estimated $39.2M sold.
Based on aggregated 13F filings for Q1 2024.